X-ray crystallographic analysis of 3-(2'-phenyl-2,4'-bithiazole-4-carboxamido) propyldimethylsulphonium iodide, an analogue of the DNA-binding portion of bleomycin A2. by Kuroda, R et al.
volume 10 Number 151882 Nucleic Acids Research
X-Ray crystaOognphic analysis of 3^2'-phenyl-2,4M>itniazole-4-carboxanildo)propyklnnethylsulph-
onium iodide, an analogue of the DNA-binding portion of bfeomydn A 2
Reiko Kuroda, Stephen Neidlet, James M.Riordan* and Ted T.Sakai
Cancer Research Campaign Biomolecular Structure Research Group, Department of Biophysics,
King's College, 26-29 Drury Lane, London WC2B 5RL, UK, and Department of Biochemistry and
the Comprehensive Cancer Center, University of Alabama, Birmingham, AL 35924, USA
Received 19 May 1982; Revised and Accepted 24 June 1982
ABSTRACT
The crystal and molecular structure of the title compound, an analogue
of the DNA binding region of bleomycin Aj, has been determined by X-ray
crystallography. All the three independent molecules In an asymmetric unit
are approximately planar with fully extended side chains.
A computer graphics model-building study has shown that the phenyl group
and the second thiazole ring can be intercalated between the base pairs of the
double-stranded deoxydinucleoside phosphate d(CpG), and also that the sulphon-
ium cation can interact with a backbone phosphate group. This model is in
accord with NMR spectral data.
INTRODUCTION
The bleomycins are a group of closely-related antibiotics useful in the
treatment of various types of cancer, especially squamous cell carcinomas,
testicular cancers and cancers of the head and neck (1). The drugs are bel-
ieved to act by degrading cellular DNA and recent evidence suggests that the
ultimate agent of DNA damage is some form of activated reduced oxygen, pro-
duced as a consequence of oxidation of bleomycin-chelated Fe(II) to Fe(III) in
a quaternary DNA.bleomycin.iron.oxygen complex (1). The drug molecule itself
may be divided into two regions) the DNA-binding portion, containing the bith-
iazole moiety and the terminal amine and the metal ion-chelating part, com-
prising most of the remainder of the molecule (figure 1).
Physical methods such as ESR (2-6), NMR (7-11) spectroscopy and single
crystal diffraction (9) have been intensively used for the study of bleomycin
itself and/or its components and biosynthetic precursors. However the struc-
ture of the activated bleomycin species is not known with certainty and the
mechanism of the DNA damage is still at the stage of speculation. So far only
one model metal complex has been reported which is biologically active, pro-
ducing oxygen sensitive complex with Fe(II) at physiological values of pH (12).
NMR studies show (13,14) that the bithiazole and terminal amine are the
moities most strongly associated with DNA. Whether the bithiazole intercal-
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DNA BINDING REGION
I
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Figure 1. Structure of bleomycin A2 showing the DNA binding region of the
molecule. Arrows on the left indicate likely ligands for metal ion binding.
ates between DNA bases or simply binds in the minor groove is disputed.
Bleomycin is reported to cause an increase in the length of DNA, and to un-
wind DNA in a manner characteristic of classical intercalators. In addition,
electric dichroism measurements indicate that the bithiazole rings are parallel
to the base pairs in DNA-bleomycin complexes (15,16). However NMR studies of
the poly (dA-dT) .poly (dA-dT)-bleomycin A2 complex show that the bithiazole
protons do not experience the large upfield shifts normally associated with
an intercalative interaction (14,17).
The terminal amine is believed necessary for the formation of an ionic
bond between the drug and the negatively charged nucleic acid backbone so
that the drug is brought in close proximity to its target. It is known that
loss of the terminal amine (to give the acid) renders bleomycin inactive (18).
Removal of the cationic charge of bleomycin A2 to give the demethyl-A2 deriv-
ative results in a decrease in the rate of DNA degradation, suggesting that
the decrease in rate is the result of a lower frequency of interaction of the
drug with the DNA (19,21).
Several compounds modelling the DNA binding region of bleomycin A2 have
been synthesized and their interactions with poly (dA-dT) . poly (dA-dT) have
been investigated by NMR spectroscopy for the purpose of designing synthetic
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derivatives of bleomycin. Derivatives of 2-phenylthiazole-4-carboxylic acid
and 2'-phenyl-2,4'-bithiazole-4-carbcocylic acid containing the 3-aminopropyl-
dimethyl-sulphonium side chain of bleomycin A2 were found to intercalate in
poly (dA-dT) .poly (dA-dT) to a much greater extent than 2'-alkyl substituted
2,4'-bithiazole derivatives structurally similar to the parent compound.
These data show that steric constraints play an important role in the binding
of the parent bleomycins to DNA> furthermore, the data suggest the possibility
that the interaction of bleomycin analogues could be manipulated by appro-
priate choice of side chain substituents and/or intercalating groups. In the '
present study, the structure of the phenylbithiazole analogue has been studied
by X-ray crystallography, and its possible interaction with a DNA fragment
examined by model-building. These studies provide information about the poss-
ible nature of complexes of these analogues with DNA. Ultimately, it is
hoped that they will enable the rational design of DNA ligands having specific
binding properties.
EXPERIMENTAL
The preparation of the compound is described elsewhere. The material
was obtained as fine needles upon crystallization from a mixture of methanol
and water.
Accurate cell dimensions were obtained by measurement of 25 6 values on
an Enraf-Nonius CAD4 diffractometer, after a preliminary examination by
Weisenberg photography. The intensity data were collected on the diffracto-
meter with Cu-Ka radiation, operated in the 9-29 scan mode up to 9=50°. A
periodic check on intensities data were corrected anisotropically for
decomposition. The maximum and average correction factors were 1.25 and 1.08,
respectively.
Crystal Data:- CnH2oISsNiO. Molecular Weight 517.48, triclinic, a = 5.434
(1), b - 36.129(2), c = 26.314(3)A, a = 120.24(1), 0 - 97.86(1), y = 86.06(1)°,
U - 3179.5(1.6)AJ, D = 1.612 g cm"', B - 6,F(O0O) = 1548, space group pi, u
(Cu-Ka) •= 147.7 cm"1.
The crystal available for the data collection was very small (0.14x0.02
x 0.007 mm). Therefore the intensity data was measured with Cu-Ka radiation
in spite of the high u value. Out of 7515 observed reflections only 3373
satisfied I >_ la(I)> 2573 reflections with I >_ 3a(I) were used for the struc-
ture refinement. As the intensity statistics showed a centric structure, the
space group Pi was adopted with three independent molecules per asymmetric
unit. The structure was solved by the heavy-atom technique combined with
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Table 1. Atomic
ATOM
11
12
13
SI
S2
S3
S4
S5
S6
S7
S8
S9
01
02
03
Nl
N2
N3
N4
N5
N6
N7
N8
N9
Cl
C2
C3
C4
C5
C6
C7
C8
C9
CIO
Cll
C12
C13
C14
CIS
C16
C17
C18
C19
C20
C21
C22
C23
C24
C25
C26
C27
C28
C}9
C30
coordinates with
X
0.3264(4)
0.1230(4)
0.8184(4)
-0.198(2)
0.358(2)
0.944(2)
0.150(2)
1.098(2)
1.593(2)
1.378(2)
0.581(2)
0.192(2)
-O.?19(4)
0.398(4)
1.161 (4)
-0.059(4)
0.294(4)
0.768(4)
0.505(4)
0.924(4)
1.490(4)
1.090(4)
0.729(4)
0.252(4)
-0.475(7)
-0.143(5)
-0.331(5)
-0.138(5)
-0.235(5)
-0.072(5)
0.114(5)
0.113(5)
0.431(5)
0.624(5)
0.705(5)
0.939(5)
1.103(5)
1.060(5)
1.220(6)
1.428(6)
1.460(5)
1.319(6)
-0.154(6)
0.225(6)
0.089(6)
0.327(5)
0.290(6)
0.538(5)
0.769(5)
0.825(5)
1.112(5)
1.311(5)
1.334(5)
1.644(5)
estimated standard
Y
0.30523(7)
0.49228(8)
0.20243(7)
0.4725(3)
0.3209(3)
0.2148(3)
0.1770(3)
-0.0617(2)
0.1369(3)
0.6497(3)
0.2594(3)
0.3518(3)
0.4410(6)
-0.0637(6)
0.3768(7)
0.4049(7)
0.3410(7)
0.2441 (7)
0.0312(7)
0.0209(7)
0.0311 (7)
0.4360(7)
0.3616(7)
0.2738(7)
0.4940(12)
0.3998(10)
0.4616(9)
0.4348(9)
0.4354(9)
0.4099(8)
0.3745(9)
0.3676(9)
0.3116(9)
0.2748(10)
0.2632(9)
0.2106(8)
0.1727(9)
0.1659(9)
0.1300(10)
0.1020(10)
0.1116(9)
0.1474(10)
0.1949(11)
0.2348(11)
0.1174(10)
0.0976(9)
0.0436(10)
-0.0209(9)
-0.0253(9)
-0.0735(9)
0.0090(9)
0.0480(9)
0.1036(9)
0.0734(9)
deviations
Z
0.50780(7)
0.79745(7)
0.69465(8)
0.6497(3)
0.2588(3)
0.3516(3)
0.5277(3)
0.6793(3)
0.7843(3)
0.1775(3)
-0.0614(3)
0.1365(3)
0.3770(6)
0.5592(6)
-0.0645(7)
0.4361 (7)
0.3620(7)
0.2759(7)
0.5952(7)
0.6592(7)
0.7555(7)
0.0320(7)
0.0208(7)
0.0313(7)
0.6915(12)
0.6354(10)
0.5782(9)
0.5336(9)
0.4778(9)
0.3890(9)
0.3490(9)
0.2939(9)
0.3209(9)
0.3224(9)
0.3688(9)
0.2831(8)
0.2380(9)
0.1832(9)
0.1424(10)
0.1564(10)
0.2123(9)
0.2559(10)
0.5070(11)
0.5997(11)
0.5391(10)
0.5639(9)
0.5649(10)
0.5909(9)
0.6264(9)
0.6321(9)
0.6882(9)
0.7254(9)
0.7362(9)
0.7888(9)
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Table 1.
C31
C32
C33
C34
C35
C36
C37
C38
C39
C40
C41
C42
C43
C44
C45
C46
C47
C48
C49
C50
C51
C52
C53
C54
(continued)
1.869(5)
2.059(5)
2.252(5)
2.268(6)
2.073(6)
1.880(5)
1.654(6)
1.370(6)
1.451(5)
1.238(5)
1.277(5)
1.057(5)
0.863(5)
0.803(6)
0.582(5)
0.411(6)
0.405(6)
0.141(5)
-0.037(5)
-0.201(5)
-0.356(5)
-0.365(6)
-0.214(6)
-0.051(6)
0.0684(9)
0.1096(10)
0.1005(9)
0.0539(10)
0.0140(11)
0.0199(9)
0.6900(11)
0.6354(11)
0.5781(9)
0.5363(9)
0.4772(9)
0.3881(9)
0.3464(9)
0.2930(10)
0.3208(9)
0.3200(10)
0.3703(10)
0.2839(9)
0.2396(8)
0.2557(8)
0.2113(10)
0.1538(10)
0.1456(11)
0.1856(10)
0.8275(9)
0.8551(10)
0.8883(9)
0.8976(10)
0.8721(11)
0.8330(9)
0.1970(11)
0.2340(11)
0.1170(9)
0.1010(9)
0.0437(9)
-0.0220(9)
-0.0260(9)
-0.0744(10)
0.0096(9)
0.0465(10)
0.1063(10)
0.0735(8)
0.0660(8)
0.1091(8)
0.0981 (10)
0.0527(11)
0.0146(11)
0.0191(10)
direct methods. Three iodine atoms were located from the Patterson map in
conjunction with examination of the second most consistent E map. The sub-
sequent difference Fourier map at R = 0.346 showed some strong peaks, out of
which nine seemed to represent reasonable geometry for three sulphurs in each
of three molecules. This assignment gave acceptable intermolecular contacts
for the atoms, as well as being consistent with the vector map.
Least-squares refinement with the iodine and sulphur atoms converged to
an R factor of 0.236 and the subsequent difference map revealed all but one
carbon atom of molecule I but only half of the structure of molecules II and
III. Several cycles of least-squares refinements including these located
atoms reduced the R factor to 0.147 and the rest of the structure was re-
vealed in the subsequent difference map. Least-squares refinement with aniso-
tropic temperature factors for the iodine and sulphur atoms and isotropic
temperature factors for the rest of the atoms converged to an R factor of
0.064. Amide hydrogen atoms and some of the CH2 and CHj hydrogen atoms were
located in a subsequent difference map. Accordingly these atoms were assigned
their observed positions and the remaining ones were generated assuming a
near-ideal geometry of the functional groups. The hydrogen atoms were in-
cluded in the structure factor calculations but their parameters were not
refined. The final R factor was 0.057. Unit weights were assigned to all
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reflections. Table 1 gives the final atomic coordinates. Thermal parameters
and structure factors are available on request from S.N.
Computer graphics analyses were made using programs written by S.A. Islam
at King's College. These were performed on a Tektronix 4025A raster scan ter-
minal linked to a PDP 11/34 computer. Coordinates for the deoxydinucleoside
phosphate intercalative geometry were taken from the study of d(CpG) with
proflavina (22). It has been shown elsewhere (23,24) that the backbone
conformation of intercalated dinucleosides (whether ribo- or deoxy-) is
approximately constant regardless of the nature of the interacting drugj this
data set is the most accurate available for deoxydinucleoside-monophosphate -
drug complexes.
RESULTS AND DISCUSSION
Molecular Structure: There are three independent molecules, I, II and III in
an asymmetric unit. The geometry of the three molecules is very similar in-
dicating that crystal packing forces do not dominate the conformation of this
apparently rather flexible molecule. Average bond lengths and angles over
the three molecules are given in Table 2 and averaged geometry is considered
for much of the discussion which follows.
The molecule is approximately planar (figure 2). The two thiazole rings
of bithiazole form an angle of 1.7° to each other for all three independent
molecules and the electrons are therefore presumably delocalized over the two
rings. This value compares closely with that of 6 in the bithiazole-contain-
ing component of bleomycin (25). The absence of 1' and 3' substituents on the
bithiazole system allows the phenyl ring to be coplanar with the bithiazole
rings. This is in contrast to biphenyl systems in which even hydrogen-
hydrogen interactions suffice to skew the rings with respect to one another.
The central C-C distance of a bithiazole is 1.41A, averaged over the molecules
and the two rings are trans to each other. The terminal phenyl ring is
slightly rotated about its exocyclic bond, forming a dihedral angle of 10.2
to the adjacent bithiazole ring. The maximum deviation of a non-hydrogen
atom from the bithiazole ring plane is 0.85A for one of the terminal S-methyl
carbon atom with the rest of the atoms only 0.03 - 0.36A away from the plane.
The peptide groups are planar but the hydrogen atoms are slightly off the
plane: 0.44, 0.05, 0.28A for molecules I, II and III respectively. This is
due to an intramolecular interaction with the nitrogen atom of the first
thiazole (N2...HN1 = 2.22A, N5...HN4 - 2.15A, N8...HN7 - 1.43&). The torsion
angles around the peptide bond averaged over the three molecules are included
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Table 2. Average bond lengths (A) and angles (°), and peptide torsion
angles for each molecule: numbering of atoms is for molecule I.
SI - Cl
SI - C2
SI - C3
C3 - C4
C4 - C5
C5 - Nl
Nl - C6
C6 - 01
C6 - 07
C7 - C8
C8 - S2
S2 - C9
C9 - N2
N2 - C7
C9 - CIO
CIO - Cll
Cll - S3
S3 - C12
C12 - N3
N3 - CIO
C12 - C13
C13 - C14
C14 - C15
C15 - C16
C16 - C17
C17 - C18
C18 - C13
1.80(1)
1.73(1)
1.80(1)
1.53(1)
1.50(1)
1.43(1)
1.32(1)
1.22(1)
1.50(1)
1.36(1)
1.74(1)
1.75(1)
1.28(1)
1.37(1)
1.41(1)
1.40(1)
1.70(1)
1.73(1)
1.27(1)
1.38(1)
1.49(1)
1.38(1)
1.37(1)
1.38(1)
1.35(1)
1.38(1)
1.37(1)
Cl - SI - C2
Cl - SI - C3
C2 - SI - C3
SI - C3 - C4
C3 - C4 - C5
C5 - Nl - C6
Nl - C6 - 01
Nl - C6 - C7
01 - C6 - C7
C6 - C7 - C8
C6 - C7 - N2
C7 - C8 - S2
C8 - S2 - C9
C7 - N2 - C9
N2 - C9 - C10
N2 - C9 - S2
S2 - C9 - C10
C9 - CIO - Cll
C9 - CIO - N3
Cll - CIO - N3
CIO - Cll - S3
Cll - S3 - C12
CIO - N3 - C12
N3 - C12 - C13
N3 - C12 - S3
S3 - C12 - C13
C12 - C13 -C18
C14 - C13 -C18
C13 - C14-C15
C14 - C15 -C16
C16 - C17 -C18
C17 - C18-C13
C5 - Nl - C6 -
C5 - Nl - C6 -
01 - C6 - C7 -
103.3(6)
102.4(6)
102.6(5)
110.3(8)
111(1)
119.6(9)
126(1)
113(1)
121(1)
123(1)
121.9(9)
110.2(8)
88.5(5)
112.5(9)
126(1)
114.2(8)
119.2(9)
124(1)
123(1)
114(1)
109.1(9)
90.2(5)
109.1(9)
122.2(9)
114.6(8)
123.1(8)
119(1)
120(1)
117(1)
125(1)
124(1)
119(1)
01 5(1)
C7 -175(2)
C8 -8(1)
in Table 2.
The three independent molecules in an asymmetric unit are related by a
pseudo-threefold symmetry of rotation along tha crystallographic (i - axis
(figure 3). As the phenyl and the bithiazole rings are slightly rotated with
respect to each other, the molecule is chiral depending on the sense of rota-
tion. The unit cell contains equal number of molecules of optical antipode
(space group pi) and all the three molecules arranged around a pseudo-three-
fold axis have the same chirality. The 3-aminopropyldimethylsulphonium side
chains of the adjacent molecules are anti-parallel to each other as they are .re-
lated by inversion centres and there is no contact closer than 3.94& between
them. Each iodine atom is close to two sulphur atoms) one from thiazole of
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01.
Figure 2. Molecular structure with numbering scheme.
one molecule, and the other from a side chain of another molecule (II...S3 -
3.918A, II...S4 ° 3.844A 12...SI = 3.830A, 12...S9 = 3.907A, I3...S6 = 3.89lA,
13...S7 - 3.834A).
Bithiazole-containing derivatives whose structures have been solved by
X-ray crystallography all appear to exhibit the trans orientation of the two
rings. These include the isolated bithiarole component of bleomycin, the
antibiotic micrococcin P (26), and the derivative described above (25) . This
orientation is presumably dictated by unfavourable interactions between the
Cjl-hydrog«n atom of one thiarole ring and the electrons of the sulphur atom
of the other ring. These data suggest that intercalation of the bithaiazole
system of bleooiycin or its analogues would occur with the rings in a tiana
orientation, in contrast with the cis orientation assumed in a recent study
(28).
H NMR spectra with poly (dA-dT) .poly (dA-dT) show (17) that there is a
stronger ring currant effect of the DNA bases on the phenyl ring (0.41, 0.70
ppm) and on the second thiazole ring (0.86 ppm), but a smaller effect on the
first thiazole ring (0.35 ppm) and the side chain hydrogens (0.01 ppm). This
indicates that the side chain and the first thiazole ring, to some extent,
ara further away from the base-pair region of DNA. In the crystal structure,
the side chain is fully extended and the long axis of the bithiazole ring and
the side chain long) form an angle of ca. 95 . The long axis and the
exocyclic bond of the phenyl ring form an angle of ca. 135° (figure 2) .
Therefore it may be possible for the phenyl and the second thiazole ring to
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Figure 3. Stereo view of the unit cell along the a_ axis.
be intercalated between the base pair of duplex DKA and at the same time for
the sulphonium cation to interact with the negative phosphate group. Our
modal-building study shows that such a position is energetically favourable
(figure 4 ) . This orientation of the bleomycin derivative forces the first
thiazole ring and the side chain out of the base pair region, hence this may
explain the weak ring current felt by these protons.
In comparison, the analogous hydrogens of bleomycin itself experience
smaller high field shifts in the presence of poly (dA-dT) .poly (dA-dT), with
a maximum of approximately 0.3-0.4 ppm (14,17). Similar observations have
been made in two studies of bleomycin fragments with poly (dA-dT) .poly
(dA-dT) and with self-complementary deoxydinucleoside monophosphates (27,28).
in each case, both H5 and H5' resonances of the bithiazole rings exhibit the
same shifts. It has been inferred from this data that the bithiazole hydro-
gens take a cis orientation in complexes with daoxydinucleoside monophosphates
with both hydrogens pointed in toward the base pair region. In the absence
of differential effects, however, it is difficult to formulate a precise
model for this orientation from such NMR measurements. It can be shown, for
instance, that numerous els and trans orientation of the bithiazole system
can be found which allow both hydrogens to experience the same shielding
effects using the contours of Giessner-Prettre and Pullman (29,30).
Eere, we feel that the availability of the crystal structure of the free
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Figure 4. Stereo views of the intercalation model for the bleomycin
derivative complexed to d (CpG).
ligand together with the observation of differential effects on hydrogen of
the ligand in NMR studies of nucleic acid complexes allows us with some degree
of certainty to propose a model for an intercalation complex (figure 4). A
more detailed, quantitative study of the interaction of the molecule with
models for DNA is currently underway.
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